Project Details
Description
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. The absence of current therapies has resulted in a significant economic burden associated with this debilitating and irreversible disease. This project will investigate the therapeutic potential of the bodys own natural delivery vehicles called extracellular vesicles (EV). Along with the molecular cargo contained in EVs we will harness this as a treatment to slow down the progression of AMD.
Status | Active |
---|---|
Effective start/end date | 1/01/21 → 31/12/25 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.